Combined NK-CIK and PD-1 inhibitor (nivolumab), an effective immunotherapy for treating intrahepatic lymphoepithelioma-like cholangiocarcinoma unassociated with EBV infection: Two case reports and a literature review

Intrahepatic lymphoepithelioma-like cholangiocarcinoma (LELCC) is a very rare malignant tumor arising from the biliary epithelium. To date, there has been a lack of evidence on the radiographical features, clinicopathological features, and treatment modalities of LELCC, with less than 28 cases of LE...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Alen Sam Saji, Biao Yang, Wan Ting Hou, Xia Liu, Qiu Ping Ren, Yuan Feng Wei, Yu Zu Zhang, Xi Yang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Subjects:	liver lymphoepithelioma-like carcinoma cholangiocarcinoma EBV nivolumab
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1090580/full